期刊文献+

氯沙坦对兔动脉粥样硬化影响的实验研究 被引量:3

Anti-atherosclerotic Effects of Losartan in Rabbits Fed with A High-Cholesterol Diet
下载PDF
导出
摘要 目的了解氯沙坦的抗动脉粥样硬化 (atherosclerosis,AS)作用及其机制。 方法通过高脂饮食及内皮损伤术建立兔AS模型 ,一组用氯沙坦 (2 5mg·kg-1·d-1) ,另一组不用 ,并设正常对照组 ,喂养 4个月 ,观察血管内膜、血管壁血管紧张素Ⅱ (AII)含量及内膜巨噬细胞的变化。 结果氯沙坦治疗组兔主动脉内膜面积及内膜厚度等参数均小于未治疗组 ,其AII的含量亦明显低于未治疗组 ,内膜巨噬细胞阳性面积的表达率亦明显减少。 结论氯沙坦具有抗AS作用 。 Objective To investigate the role of angiotensin Ⅱ receptor antagonist losartan in the rabbit model of atherosclerosis. Methods Atherosclerosis was induced in the aortic arteries of rabbits by endothelial damage after feeding with an atherogenic diet for 4 months. These atherosclerotic animals were randomized to receive losartan (25mg·kg -1 ·d -1 ) or no medication, and killed in 4 months. Eight normal controls were also studied. Results Losartan induced a significant reduction in the intimal areas and angiotensin Ⅱ was significantly diminished in the aorta of the rabbits. Conclusion Block of angiotensin Ⅱ function in the vascular tissues by losartan may play an important role in preventing the development of atherosclerotic lesions.
出处 《上海第二医科大学学报》 CSCD 2002年第2期128-130,共3页 Acta Universitatis Medicinalis Secondae Shanghai
基金 卫生部自然科学基金项目 (96-2 -2 79)
关键词 氯沙坦 动脉粥样硬化 血管紧张素Ⅱ 实验研究 losartan atherosclerosis angiotensin Ⅱ
  • 相关文献

参考文献6

  • 1[1]Kranzhofer R, Schmidt J, Pferffer CAH, et al. Angiotensin induces inflammatory activation of human vascular smooth muscle cells[J]. Arterioscler Thromb Vasc Biol, 1999,19:1623-1629. 被引量:1
  • 2[2]Chen H, Li D, Mehta JL. Attenuation of tissue P-selectin and MCP-1 excpression and intimal proliferation by AT1 receptor blockade in hyperlipidemic rabbits[J].Biochem Biophy Res Commun, 2001,282:474. 被引量:1
  • 3[3]Li J, Hirose N, Kawamura M, et al. Antiatherogenic effect of angiotensin converting enzyme inhibiter and angiotensin 11 receptor antagonist in the cholesterol fed rabbits[J].Atherosclerosis,1999,143:315-326. 被引量:1
  • 4[4]Fennessy PA, Campbell JH, Mendelsohn FA, et al. Angiotensin-converting enzyme inhibitors and atherosclerosis:relevance of animal models to human disease[J]. Clin Exp Pharmacol Physiol, 1996,23:s30-s32. 被引量:1
  • 5[5]Keidar S, Attias J, Smith J, et al. The angiotensin Ⅱ receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice[J]. Biochem Biophys Res Commun, 1997,236:622-625. 被引量:1
  • 6[6]Miyazaki M, Sakonjo H, Takai S, et al. Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin 11 antagonist in cynomolgus monkeys fed a high cholesterol diet[J]. Br J Pharmacol, 1999,128:523-529. 被引量:1

同被引文献31

  • 1Rajagopalam S, Kurz S, Munzel T, et al. Angiotensin Ⅱmediated hypertension in the rat increases vascular superoxide production via memberane NADH/NADPH oxidase activation:contribution to alterations of vasomotor tone [J]. J Clin Invest, 1996, 97:1916. 被引量:1
  • 2Hornig B, Kohler C, Schlink D, et al. AT1-receptor antagonism improves endothelial function in coronary artery disease by a bradykinin/B2-receptor-dependent mechanism [J]. Hypertension, 2003,41 (5): 1092. 被引量:1
  • 3Koike H. New pharmacologic aspects of CS-866, the newest angiotensin Ⅱ receptor antagonist [J]. Am J Cardiol, 2001,87(8A):33C. 被引量:1
  • 4Chen XL, Tummala PE, Olbrych MT, et al. Angiotensin Ⅱ induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells [J]. Circ Res, 1998, 83(9):952. 被引量:1
  • 5Proudfoot JM, Croft KD, Puddey IB, et al. Angiotensin Ⅱ-type 1 receptor antagonists inhibit basal as well as lowdensity lipoprotein and platelet-activating factor-stimulated human monocyte chemoattractant protein-1 [J]. J Pharmacol Exp Ther, 2003,305(3):846. 被引量:1
  • 6Yanagitani Y, Rakugi H, Okamura A, et al. Angiotensin Ⅱ type 1 receptor-mediated peroxide production in human macrophages [J]. Hypertension, 1999, 33 (1 Pt 2):335. 被引量:1
  • 7Weber H,Taylor D, Molloy JL. Angiotensin Ⅱ induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells [J]. J Cli Invest, 1995,93:788. 被引量:1
  • 8Herbert JM, Delisee C, Dol F, et al. Effect of SR 47436, a novel angiotensin Ⅱ AT1 receptor antagonist, on human vascular smooth muscle cells in vitro [J]. Eur J Pharmacol, 1994,251 (2-3): 143. 被引量:1
  • 9Kohno M, Ohmori K, Nozaki S, et al. Effects ofvalsartan on angiotensin Ⅱ-induced migration of human coronary artery smooth muscle cells [J]. Hypertens Res, 2000, 23(6):677. 被引量:1
  • 10Watanabe T, Pakala R, Katagiri T, et al. Mildly oxidized low-density lipoprotein acts synergistically with angiotensin Ⅱ in inducing vascular smooth muscle cell proliferation [ J ]. J Hypertens, 2001,19(6): 1065. 被引量:1

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部